Know Cancer

or
forgot password

IVF/ICSI Outcomes of OCP Plus GnRH Agonist Protocol Versus OCP Plus GnRH Antagonist Fixed Protocol in Women With PCOS


N/A
20 Years
35 Years
Not Enrolling
Female
PCOS GnRH Antagonist and GnRH Agonist IVF/ICSI Cycles

Thank you

Trial Information

IVF/ICSI Outcomes of OCP Plus GnRH Agonist Protocol Versus OCP Plus GnRH Antagonist Fixed Protocol in Women With PCOS


Women with PCOS undergoing IVF/ICSI cycles will be evaluated by two different protocols. One
arm of the study includes oral contraceptive plus GnRH agonist protocol with 150 IU FSH
(standard dose) and second arm includes oral contraceptive plus GnRH Antagonist with 150 IU
FSH dose and fixed 6th day starting of GnRH Antagonist.


Inclusion Criteria:



- PCOS women undergoing ICSI cycles

- All women will be administered 150 IU rec FSH

Exclusion Criteria:

- Women having other endocrinopathies

- women older than 35

- third IVF/ICSI cycles

- previous and current use of metformin

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator)

Outcome Measure:

Ongoing pregnancy rates

Outcome Description:

Ongoing pregnancy rates measured in OCP plus GnRH Agonist and OCP plus GnRH Antagonist cycles in women with PCOS

Outcome Time Frame:

March 2009 to June 2011

Safety Issue:

No

Principal Investigator

Bulent Haydardedeoglu, M.D.

Investigator Role:

Study Chair

Investigator Affiliation:

Baskent University

Authority:

Turkey: Baskent University

Study ID:

BH532008

NCT ID:

NCT01354275

Start Date:

March 2009

Completion Date:

June 2011

Related Keywords:

  • PCOS GnRH Antagonist and GnRH Agonist IVF/ICSI Cycles
  • PCOS
  • IVF/ICSI
  • Clinical Pregnancy rates
  • GnRH Antagonist
  • GnRH Agonist
  • Polycystic Ovary Syndrome

Name

Location